Driven to Advance Your Preclinical Research
MI Bioresearch (MI), the preclinical oncology solutions business of Covance, offers in vitro and in vivo oncology pharmacology research services to support your drug discovery and development programs. Our team helps you explore the effects of your drugs and biologics using an expansive bank of human and syngeneic cancer cell line models, the CRO industry’s most comprehensive array of preclinical tools, and the expertise to apply them to maximum benefit.
Our team has a deep oncology pedigree, with many years of successful pharma or biotech-based preclinical leadership and an appreciation for the pressure clients are under for cost-effective results.
MI Bioresearch’s mission is to advance your preclinical oncology drug development programs by combining our expertise, tools, and models to provide you with powerful, decision-driving data.
- Apply a disciplined scientific approach to your preclinical research.
- Maintain currency in the rapidly evolving understanding of cancer and the potential options available to treat the disease.
- Remain highly flexible to respond to your needs and optimize your investment without compromising the scientific integrity of your results.
- Build strong, meaningful collaborative relationships.